{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:28:30Z","timestamp":1773811710305,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.preghy.2021.06.005","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T11:45:59Z","timestamp":1623498359000},"page":"171-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Screening for primary aldosteronism in pregnancy"],"prefix":"10.1016","volume":"25","author":[{"given":"Sneha","family":"Vidyasagar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.preghy.2021.06.005_b0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","article-title":"Current pattern of primary aldosteronism diagnosis: Delayed and complicated","volume":"47","author":"Lim","year":"2018","journal-title":"Aust J Gen Pract."},{"key":"10.1016\/j.preghy.2021.06.005_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.hjh.0000467473.21331.70","article-title":"Lb01.11: Prevalence of Secondary Hypetension in Young Hypertensive Adults","volume":"33","author":"Camelli","year":"2015","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.preghy.2021.06.005_b0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.preghy.2015.08.003","article-title":"Primary aldosteronism and pregnancy","volume":"5","author":"Morton","year":"2015","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.005_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ccr3.355","article-title":"Eplerenone use in primary aldosteronism during pregnancy","volume":"4","author":"Gunganah","year":"2016","journal-title":"Clin Case Rep."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.005_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ando.2016.04.009","article-title":"Primary aldosteronism and pregnancy","volume":"77","author":"Landau","year":"2016","journal-title":"Ann Endocrinol (Paris)."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.005_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000506287","article-title":"Primary Aldosteronism and Pregnancy","volume":"45","author":"Zelinka","year":"2020","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.preghy.2021.06.005_b0035","article-title":"Primary aldosteronism and pregnancy","volume":"41","author":"Zelinka","year":"2016","journal-title":"Endocrine Abstracts."},{"key":"10.1016\/j.preghy.2021.06.005_b0040","article-title":"A challenging case of primary aldosteronism presenting in pregnancy","volume":"50","author":"Ghela","year":"2017","journal-title":"Endocrine Abstracts."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.005_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9343(80)90178-3","article-title":"Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy","volume":"68","author":"Wilson","year":"1980","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.preghy.2021.06.005_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11906-015-0563-z","article-title":"Secondary Hypertension in Pregnancy","volume":"17","author":"Malha","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.005_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316657450","article-title":"Aldosterone\/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis","volume":"17","author":"Li","year":"2016","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.005_b0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.116.08407","article-title":"Novel Approach to Establishing an Aldosterone: Renin Ratio Cutoff for Primary Aldosteronism","volume":"69","author":"Leung","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.06.005_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-3182-8_5","article-title":"Quantitation of Aldosterone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS\/MS)","volume":"1378","author":"Van Der Gugten","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.005_b0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.005_b0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ando.2016.02.003","article-title":"SFE\/SFHTA\/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps","volume":"77","author":"Douillard","year":"2016","journal-title":"Ann Endocrinol (Paris)."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.005_b0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.9738\/CC140.1","article-title":"Predictors of successful outcome after adrenalectomy for primary aldosteronism","volume":"97","author":"Wang","year":"2012","journal-title":"Int. Surg."},{"issue":"10008","key":"10.1016\/j.preghy.2021.06.005_b0085","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.preghy.2021.06.005_b0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"03","key":"10.1016\/j.preghy.2021.06.005_b0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.preghy.2021.06.005_b0100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00005344-197911000-00003","article-title":"Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients","volume":"1","author":"Lijnen","year":"1979","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.005_b0105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9149(78)90017-6","article-title":"Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion","volume":"41","author":"Weidmann","year":"1978","journal-title":"Am. J. Cardiol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:55:45Z","timestamp":1761897345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":21,"alternative-id":["S2210778921000660"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.06.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for primary aldosteronism in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy. All rights reserved.","name":"copyright","label":"Copyright"}]}}